Negative HPV test may predict lower cervical cancer risk than a negative Pap

In the US, cotesting for human papilloma virus and Pap testing for cervical cancer every 5 years for women aged 30-65 years is now recommended. However, human papilloma virus testing alone may provide better reassurance against cervical cancer than Pap testing alone and similar reassurance to cotesting, according to a study.